Literature DB >> 30091163

Haematopoietic stem cell transplantation for mucopolysaccharidosis type VII: A case report.

Luisa Sisinni1, Mercedes Pineda2, Maria Josep Coll3, Laura Gort3, Eulalia Turon4, Montserrat Torrent1, Anna Ey5, Eva Tobajas6, Isabel Badell1.   

Abstract

Mucopolysaccharidosis type VII (MPS VII) is an inherited disease characterized by the cellular accumulation of undegraded GAGs due to the deficiency of the lysosomal enzyme β-glucuronidase. We describe a case of a 2-year-old female affected by a moderate form of MPS VII and submitted twice to HSCT with the aim of stabilizing skeletal problems and preventing neurocognitive alterations. The child underwent a second transplantation due to the rejection of the graft after a reduced-intensity conditioning in the first transplant. A myeloablative regimen allowed to achieve a stable full donor engraftment and normal enzyme levels during the 6 years of follow-up. Clinically, we observed stabilization of skeletal deformities and normal neurocognitive development. This is one of the few reports of mucopolysaccharidosis type VII treated with allogeneic HSCT.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  developmental; genetics; haematopoietic stem cell transplantation; metabolic disorders; neurology

Mesh:

Year:  2018        PMID: 30091163     DOI: 10.1111/petr.13278

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  9 in total

1.  The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis.

Authors:  Yuhua Qu; Hao Liu; Likun Wei; Shushan Nie; Wenjiao Ding; Sha Liu; Haiyan Liu; Hua Jiang
Journal:  Front Pediatr       Date:  2022-06-30       Impact factor: 3.569

Review 2.  Recent trends in mucopolysaccharidosis research.

Authors:  Hiroshi Kobayashi
Journal:  J Hum Genet       Date:  2018-11-19       Impact factor: 3.172

Review 3.  Failures of Endochondral Ossification in the Mucopolysaccharidoses.

Authors:  Zhirui Jiang; Sharon Byers; Margret L Casal; Lachlan J Smith
Journal:  Curr Osteoporos Rep       Date:  2020-10-16       Impact factor: 5.096

Review 4.  Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments.

Authors:  Kazuki Sawamoto; Molly Stapleton; Carlos J Alméciga-Díaz; Angela J Espejo-Mojica; Juan Camilo Losada; Diego A Suarez; Shunji Tomatsu
Journal:  Drugs       Date:  2019-07       Impact factor: 11.431

Review 5.  Vestronidase Alfa: A Review in Mucopolysaccharidosis VII.

Authors:  Emma H McCafferty; Lesley J Scott
Journal:  BioDrugs       Date:  2019-04       Impact factor: 5.807

Review 6.  Cell and Gene Therapies for Mucopolysaccharidoses: Base Editing and Therapeutic Delivery to the CNS.

Authors:  Chloe L Christensen; Rhea E Ashmead; Francis Y M Choy
Journal:  Diseases       Date:  2019-06-26

7.  Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII - a European caregiver survey.

Authors:  Alexandra Morrison; Esmee Oussoren; Tabea Friedel; Jordi Cruz; Nalan Yilmaz
Journal:  Orphanet J Rare Dis       Date:  2019-11-14       Impact factor: 4.123

8.  First Report of a Patient with MPS Type VII, Due to Novel Mutations in GUSB, Who Underwent Enzyme Replacement and Then Hematopoietic Stem Cell Transplantation.

Authors:  Patricia Dubot; Frédérique Sabourdy; Geneviève Plat; Charlotte Jubert; Claude Cancès; Pierre Broué; Guy Touati; Thierry Levade
Journal:  Int J Mol Sci       Date:  2019-10-28       Impact factor: 5.923

Review 9.  Non-cardiac Manifestations in Adult Patients With Mucopolysaccharidosis.

Authors:  Karolina M Stepien; Andrew Bentley; Cliff Chen; M Wahab Dhemech; Edward Gee; Peter Orton; Catherine Pringle; Jonathan Rajan; Ankur Saxena; Govind Tol; Chaitanya Gadepalli
Journal:  Front Cardiovasc Med       Date:  2022-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.